ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.869,36
0,78%
S&P 500
5.308,15
1,17%
Dow Jones
39.908,00
0,88%
Euro vs US Dollar
1,08855
0,66%
Bitcoin
65.986,78
7,23%
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. ImmuCell Corporation (ICCC)

  7. ImmuCell Corporation (ICCC) News

ICCC

ImmuCell (ICCC)

ImmuCell Corporation
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ICCC
DatumZeitQuelleÜberschriftSymbolFirma
14/05/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
14/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
14/05/202422h05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024NASDAQ:ICCCImmuCell Corporation
08/05/202419h00GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024NASDAQ:ICCCImmuCell Corporation
09/04/202422h05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024NASDAQ:ICCCImmuCell Corporation
06/03/202419h55Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
27/02/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
27/02/202422h05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023NASDAQ:ICCCImmuCell Corporation
16/02/202415h30GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023NASDAQ:ICCCImmuCell Corporation
08/01/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
08/01/202422h05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023NASDAQ:ICCCImmuCell Corporation
16/11/202321h22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
13/11/202322h05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
13/11/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
13/11/202322h05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023NASDAQ:ICCCImmuCell Corporation
07/11/202318h15GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023NASDAQ:ICCCImmuCell Corporation
05/10/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
05/10/202322h05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023NASDAQ:ICCCImmuCell Corporation
06/09/202318h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICCCImmuCell Corporation
30/08/202320h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ICCCImmuCell Corporation
29/08/202314h00GlobeNewswire Inc.ImmuCell Announces Submission of CMC Technical Section to the FDANASDAQ:ICCCImmuCell Corporation
10/08/202322h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
10/08/202322h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ICCCImmuCell Corporation
10/08/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
10/08/202322h05GlobeNewswire Inc.ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023NASDAQ:ICCCImmuCell Corporation
07/08/202318h00GlobeNewswire Inc.ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023NASDAQ:ICCCImmuCell Corporation
21/07/202315h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
13/07/202320h28Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:ICCCImmuCell Corporation
11/07/202322h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ICCCImmuCell Corporation
11/07/202322h05GlobeNewswire Inc.ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2023NASDAQ:ICCCImmuCell Corporation
 Showing the most relevant articles for your search:NASDAQ:ICCC

Kürzlich von Ihnen besucht

DBI
MDAX
MDAX
TG
NOV
Novo Nordisk
AMEX
XLV
Health Care Select Sector
USOTC
RHHBY
Roche (QX)
CCOM
US30
US 30
FX
EURGBP
Euro vs Sterling
NYSE
KO
Coca Cola
NASDAQ
AMZN
Amazon.com
CCOM
US100
US Tech 100
TG
DBK
Deutsche Bank
DBI
DAX
DAX
AMEX
XLF
Financial Select Sector
AMEX
XLE
Energy Select Sector SPDR
TG
ALV
Allianz
COIN
ETHUSD
Ethereum
TG
432
Arbor Metals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten